Investor Relations

Third Quarter Results 2008

Disclosure made according to the requirements of the Law of May 2, 2007

Agfa-Gevaert NV (Euronext: AGFB) discloses the information required under article 15 of the law of May 2, 2007 regarding the disclosure of important shareholdings in listed companies.

More

Agfa-Gevaert reports second quarter results

Agfa-Gevaert today announced its second quarter results. Mainly due to currency effects, Group sales declined 8.1 percent to 777 million Euro. In local currency, the decline was limited to 2.6 percent. Agfa Graphics' sales slightly decreased (in local currency), whereas Agfa HealthCare's competitive position suffered from the strong Euro. Agfa Specialty Products reported strong sales, mainly due to high-volume contracts with customers in the imaging industry. The Agfa-Gevaert Group's continued efforts to improve its efficiency resulted in a reduction of its Sales and General Administration costs by 25 million Euro (of which 6 million Euro due to currency effects). SG&A costs represented 22.0 percent of sales in the second quarter of 2008. However, these efforts did not suffice to compensate for the high raw material prices, the effect of the sales decline and adverse mix effects. Recurring EBIT was 38 million Euro and the net profit amounted to 3 million Euro.

More

Disclosure made according to the requirements of the Law of May 2, 2007

Agfa-Gevaert NV (Euronext: AGFB) discloses the information required under article 15 of the law of May 2, 2007 regarding the disclosure of important shareholdings in listed companies.

More

Disclosure made according to the requirements of the Law of May 2, 2007

Agfa-Gevaert NV (Euronext: AGFB) discloses the information required under article 15 of the law of May 2, 2007 regarding the disclosure of important shareholdings in listed companies.

More

Agfa-Gevaert reports first quarter results

Agfa-Gevaert today announced its first quarter results. Group sales amounted to 753 million Euro. In local currency, sales remained stable despite the continuous impact of the strong Euro, which affected the Group's competitive position, especially in the healthcare markets. Agfa-Gevaert again succeeded in substantially lowering its Sales and General Administration costs. The Group's results continued to be impacted by the evolution of the silver price, which reached record levels in the course of the first quarter. Recurring EBIT was 41 million Euro and the net profit amounted to 10 million Euro.

More

Agfa-Gevaert appoints Kris Hoornaert as Chief Financial Officer

The Board of Directors of Agfa-Gevaert announced that it has appointed Kris Hoornaert as Chief Financial Officer, effective immediately.

In this function, Kris Hoornaert replaces Anne Vleminckx.

More

Agfa-Gevaert reports fourth quarter results

Agfa-Gevaert today announced its fourth quarter results. High raw material costs continued to weigh on the Group's results and sales were affected by the strong Euro and the economic slowdown in theUSA. During the fourth quarter, Agfa-Gevaert succeeded to substantially reduce its working capital and net financial debt. Sales amounted to 864 million Euro. Recurring EBIT was 59 million Euro and the net loss amounted to 27 million Euro.

More

New Agfa-Gevaert Board members proposed to Shareholders Meeting

Agfa-Gevaert today announced that the Annual General Meeting of Shareholders of April 29, 2008 will be asked to approve the appointments of Michel Akkermans, Horst Heidsieck and Roland Junck as members of the Board of Directors, the re-election of Karel Van Miert and the extension of the mandate of Willy Duron. All of the new members have an exhaustive international experience which will bring an important added value to the company.

More